Russell Investments Group’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-33,637
| Closed | -$2.68M | – | 3371 |
|
|
2021
Q1 | $2.68M | Buy |
33,637
+4,660
| +16% | +$364K | ﹤0.01% | 1715 |
|
|
2020
Q4 | $2.29M | Hold |
28,977
| – | – | ﹤0.01% | 1685 |
|
|
2020
Q3 | $1.27M | Sell |
28,977
-6,650
| -19% | -$328K | ﹤0.01% | 1948 |
|
|
2020
Q2 | $1.57M | Sell |
35,627
-5,711
| -14% | -$213K | ﹤0.01% | 1780 |
|
|
2020
Q1 | $1.49M | Sell |
41,338
-26,966
| -39% | -$1.53M | ﹤0.01% | 1627 |
|
|
2019
Q4 | $4.84M | Sell |
68,304
-41,413
| -38% | -$3M | 0.01% | 1233 |
|
|
2019
Q3 | $8.21M | Sell |
109,717
-23,187
| -17% | -$1.97M | 0.02% | 947 |
|
|
2019
Q2 | $10.7M | Buy |
132,904
+1,212
| +0.9% | +$85.2K | 0.02% | 847 |
|
|
2019
Q1 | $8.81M | Buy |
131,692
+10,864
| +9% | +$823K | 0.02% | 962 |
|
|
2018
Q4 | $8.99M | Buy |
120,828
+4,633
| +4% | +$383K | 0.02% | 859 |
|
|
2018
Q3 | $10.7M | Buy |
116,195
+89,622
| +337% | +$8.54M | 0.02% | 899 |
|
|
2018
Q2 | $2.61M | Buy |
26,573
+407
| +2% | +$45.5K | 0.01% | 1641 |
|
|
2018
Q1 | $2.92M | Sell |
26,166
-3,944
| -13% | -$442K | ﹤0.01% | 1628 |
|
|
2017
Q4 | $3.09M | Buy |
30,110
+5,292
| +21% | +$527K | 0.01% | 1605 |
|
|
2017
Q3 | $2.34M | Buy |
24,818
+2,834
| +13% | +$224K | ﹤0.01% | 1690 |
|
|
2017
Q2 | $1.71M | Sell |
21,984
-3,541
| -14% | -$266K | ﹤0.01% | 1815 |
|
|
2017
Q1 | $2.04M | Buy |
25,525
+5,854
| +30% | +$465K | ﹤0.01% | 1746 |
|
|
2016
Q4 | $1.56M | Buy |
+19,671
| New | +$1.53M | ﹤0.01% | 1940 |
|
Russell Investments Group's CMD Position: Q2 2021 in Review
Russell Investments Group sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 33,637 shares — an estimated $2.68M sold.
Russell Investments Group first reported a position in CMD in Q4 2016 and held it in 18 quarters. The position peaked at $10.7M in Q2 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Russell Investments Group reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Russell Investments Group sold 33,637 Cantel Medical Corporation shares in Q2 2021, an estimated $2.68M.
- Russell Investments Group first reported a position in Cantel Medical Corporation in Q4 2016 and held it in 18 quarters.
- Russell Investments Group's Cantel Medical Corporation position peaked at $10.7M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.